# Study of Photopheresis in the Treatment of Erythrodermic MF and SS

> **NCT03563040** · PHASE2 · WITHDRAWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides/Sezary Syndrome

## Interventions

- **DRUG:** Methoxsalen
- **DEVICE:** THERAKOS CELLEX Photopheresis System

## Key facts

- **NCT ID:** NCT03563040
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of feasibility
- **Last updated:** 2021-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563040, "Study of Photopheresis in the Treatment of Erythrodermic MF and SS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03563040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*